Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 1997

View Archived Issues

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

Short-acting beta1-adrenoceptor blockers from U. of Melbourne

ET antagonists disclosed by Merck KGaA

Microcide reveals new cephalosporins active against resistant organisms

Opioid antagonists/agonists described by Toray

Banyu discovers potent new antitumor agent

Natural antitumor compounds described by Banyu

Inhibitors of 5alpha-reductase from Kyowa Hakko

Antiviral pyrimidine nucleosides described by Yamasa

Prodrugs of nitrogen mustard with selective antitumor activity

MP-52 to be developed worldwide by HMR

NDA to be submitted in Japan for nevirapine

Glaxo to submit NDA in Japan for lamivudine in hepatitis

Tamsulosin cleared by FDA

Protease inhibitors in Japan

PharmaSciences and BTG extend license for hydrogel drug delivery technology

Fujisawa and Solvay sign marketing agreement for antidepressant

IDEC Pharmaceuticals: Q1 1997 highlights

Novel antiinflammatory agent from Parke-Davis

Sano: Q1 1997 highlights

Neutralase effective for heparin reversal in CAB

GalaGen: Q1 1997 highlights

OXiGENE: Q1 1997 highlights

Algos: Q1 1997 highlights

BY-963 for delineation of myocardial perfusion during cardiac surgery

Clevidipine for controlling hypertension after CABG

Favorable hemodynamic profile of aptiganel during general anesthesia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...